Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBITDA Margin: 2011-2012

Historic EBITDA Margin for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -58.70%.

  • Sonoma Pharmaceuticals' EBITDA Margin rose 3995.00% to -54.46% in Q4 2012 from the same period last year, while for Dec 2012 it was -30.14%, marking a year-over-year increase of 3099.00%. This contributed to the annual value of -58.70% for FY2012, which is 2189.00% up from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported EBITDA Margin of -58.70% as of FY2012, which was up 27.16% from -80.59% recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' EBITDA Margin ranged from a high of -58.70% in FY2012 and a low of -80.59% during FY2011.
  • Over the past 2 years, Sonoma Pharmaceuticals' median EBITDA Margin value was -69.65% (recorded in 2012), while the average stood at -69.65%.
  • Data for Sonoma Pharmaceuticals' EBITDA Margin shows a peak YoY skyrocketed of 2,189bps (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' EBITDA Margin stood at -80.59% in 2011, then skyrocketed by 2,189bps to -58.70% in 2012.